All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Optimized assembly of functionalized-neuroblastoma targeting EcLHFRT nanocarriers

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62156489%3A43210%2F20%3A43919628" target="_blank" >RIV/62156489:43210/20:43919628 - isvavai.cz</a>

  • Result on the web

    <a href="https://mnet.mendelu.cz/mendelnet2020/mnet_2020_full.pdf" target="_blank" >https://mnet.mendelu.cz/mendelnet2020/mnet_2020_full.pdf</a>

  • DOI - Digital Object Identifier

Alternative languages

  • Result language

    angličtina

  • Original language name

    Optimized assembly of functionalized-neuroblastoma targeting EcLHFRT nanocarriers

  • Original language description

    Biomimetic peptide ligands designed by using computational biology and in silico chemistry can bring crucial results related to their possible application in targeted anticancer therapy, more specifically in the field of active targeting of malignant neuroblastoma cell lines by modified apoferritin nanocarriers (EcLHFRT) with encapsulated cytotoxic drug. Using the high-performance throughput computing technology, unique peptides (CpTrkA, CpNGF, CpNT4) were designed and synthesized in this work. These peptides showed high affinity in silico to tropomyosin receptor kinases (TrkA, TrkB, TrkC), which are expressed on membranes of neuroblastoma cells. The main aim of this work was detailed characterization of prepared EcLHFRT nanocarriers through which we evaluated the size, stability and hemolytic properties of EcLHFRT with unmodified or modified surface insomuch as mentioned parameters are key for the further research in neuroblastoma nanomedicine. The prepared EcLHFRT nanocarriers possessed optimal size (&lt;50 nm) and stability (ζ~ -20 mV) and in contrast to free cytotoxic drug, they did not cause any hemolysis.

  • Czech name

  • Czech description

Classification

  • Type

    D - Article in proceedings

  • CEP classification

  • OECD FORD branch

    10608 - Biochemistry and molecular biology

Result continuities

  • Project

    <a href="/en/project/GA17-12816S" target="_blank" >GA17-12816S: Construction of modified apoferritin nanocarriers bearing anticancer drugs and study of mechanisms enhancing their efficiency in anticancer therapy</a><br>

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Others

  • Publication year

    2020

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Article name in the collection

    MendelNet 2020: Proceedings of International PhD Students Conference

  • ISBN

    978-80-7509-765-1

  • ISSN

  • e-ISSN

  • Number of pages

    6

  • Pages from-to

    603-608

  • Publisher name

    Mendelova univerzita v Brně

  • Place of publication

    Brno

  • Event location

    Brno

  • Event date

    Nov 11, 2020

  • Type of event by nationality

    WRD - Celosvětová akce

  • UT code for WoS article